<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2016.01522</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Active Shiga-Like Toxin Produced by Some <italic>Aeromonas</italic> spp., Isolated in Mexico City</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Palma-Mart&#x00ED;nez</surname> <given-names>Ingrid</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Guerrero-Mandujano</surname> <given-names>Andrea</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/368814/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ruiz-Ruiz</surname> <given-names>Manuel J.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hern&#x00E1;ndez-Cortez</surname> <given-names>Cecilia</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/358711/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Molina-L&#x00F3;pez</surname> <given-names>Jos&#x00E9;</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bocanegra-Garc&#x00ED;a</surname> <given-names>Virgilio</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Castro-Escarpulli</surname> <given-names>Graciela</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/303869/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laboratorio de Bacteriolog&#x00ED;a M&#x00E9;dica, Departamento de Microbiolog&#x00ED;a, Escuela Nacional de Ciencias Biol&#x00F3;gicas, Instituto Polit&#x00E9;cnico Nacional</institution> <country>Mexico City, Mexico</country></aff>
<aff id="aff2"><sup>2</sup><institution>Laboratorio Central de An&#x00E1;lisis Cl&#x00ED;nicos Unidad M&#x00E9;dica de Alta Especialidad Hospital de Pediatr&#x00ED;a &#x201C;Silvestre Frenk Freund,&#x201D; Centro M&#x00E9;dico Nacional Siglo XXI</institution> <country>Mexico City, Mexico</country></aff>
<aff id="aff3"><sup>3</sup><institution>Laboratorio de Bioqu&#x00ED;mica Microbiana, Departamento de Microbiolog&#x00ED;a, Escuela Nacional de Ciencias Biol&#x00F3;gicas, Instituto Polit&#x00E9;cnico Nacional</institution> <country>Mexico City, Mexico</country></aff>
<aff id="aff4"><sup>4</sup><institution>Departamento de Salud P&#x00FA;blica, Facultad de Medicina, Universidad Nacional Aut&#x00F3;noma de M&#x00E9;xico</institution> <country>Mexico City, Mexico</country></aff>
<aff id="aff5"><sup>5</sup><institution>Centro de Biotecnolog&#x00ED;a Gen&#x00F3;mica, Instituto Polit&#x00E9;cnico Nacional</institution> <country>Reynosa, Mexico</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: <italic>Jonathan Shaw, University of Sheffield, UK</italic></p></fn>
<fn fn-type="edited-by"><p>Reviewed by: <italic>Iddya Karunasagar, Nitte University, India; Susana Merino, University of Barcelona, Spain</italic></p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x002A;Correspondence: <italic>Graciela Castro-Escarpulli, <email>chelacastro@hotmail.com</email></italic></p></fn>
<fn fn-type="other" id="fn002"><p><sup>&#x2020;</sup> <italic>These authors have contributed equally to this work.</italic></p></fn>
<fn fn-type="other" id="fn003"><p>This article was submitted to Aquatic Microbiology, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>09</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>7</volume>
<elocation-id>1522</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>06</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>09</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2016 Palma-Mart&#x00ED;nez, Guerrero-Mandujano, Ruiz-Ruiz, Hern&#x00E1;ndez-Cortez, Molina, Bocanegra-Garc&#x00ED;a and Castro-Escarpulli.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Palma-Mart&#x00ED;nez, Guerrero-Mandujano, Ruiz-Ruiz, Hern&#x00E1;ndez-Cortez, Molina, Bocanegra-Garc&#x00ED;a and Castro-Escarpulli</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Shiga-like toxins (Stx) represent a group of bacterial toxins involved in human and animal diseases. Stx is produced by enterohemorrhagic <italic>Escherichia coli, Shigella dysenteriae</italic> type 1, <italic>Citrobacter freundii</italic>, and <italic>Aeromonas</italic> spp.; Stx is an important cause of bloody diarrhea and hemolytic uremic syndrome (HUS). The aim of this study was to identify the <italic>stx</italic>1<italic>/stx</italic>2 genes in clinical strains and outer membrane vesicles (OMVs) of <italic>Aeromonas</italic> spp., 66 strains were isolated from children who live in Mexico City, and Stx effects were evaluated in Vero cell cultures. The capacity to express active Stx1 and Stx2 toxins was determined in Vero cell cultures and the concentration of Stx was evaluated by 50% lethal dose (LD<sub>50</sub>) assays, observing inhibition of damaged cells by specific monoclonal antibodies. The results obtained in this study support the hypothesis that the <italic>stx</italic> gene is another putative virulence factor of <italic>Aeromonas</italic>, and since this gene can be transferred horizontally through OMVs this genus should be included as a possible causal agents of gastroenteritis and it should be reported as part of standard health surveillance procedures. Furthermore, these results indicate that the <italic>Aeromonas</italic> genus might be a potential causative agent of HUS.</p>
</abstract>
<kwd-group>
<kwd>Shiga-like toxin</kwd>
<kwd><italic>Aeromonas</italic> spp.</kwd>
<kwd>diarrhea</kwd>
<kwd>uremic hemolytic syndrome</kwd>
<kwd>outer membrane vesicles</kwd>
</kwd-group>
<contract-num rid="cn001">SIP 20160609</contract-num>
<contract-sponsor id="cn001">Secretar&#x013A;a de Investigaci&#x00F3;n y Posgrado, Instituto Polit&#x00E9;cnico Nacional<named-content content-type="fundref-id">10.13039/501100007161</named-content></contract-sponsor>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="23"/>
<page-count count="7"/>
<word-count count="0"/>
</counts>
</article-meta>
</front>
<body>
<sec><title>Introduction</title>
<p>For several years, the significance of <italic>Aeromonas</italic> spp., as a human diarrhea-causing agent was controversial; several studies demonstrated that the pathogenic mechanism of <italic>Aeromonas</italic> is multifactorial because many virulence factors are involved, including the production of cytotoxins (<xref ref-type="bibr" rid="B4">Castro-Escarpulli et al., 2002</xref>, <xref ref-type="bibr" rid="B5">2003</xref>). These toxins can cause diarrhea or hemorrhagic colitis, and may play a major role in the hemolytic-uremic syndrome (HUS) and TTP development (<xref ref-type="bibr" rid="B3">Bogdanovi&#x0107; et al., 1991</xref>; <xref ref-type="bibr" rid="B6">Fang et al., 1999</xref>; <xref ref-type="bibr" rid="B20">Monforte-Cirac et al., 2010</xref>).</p>
<p>The cytotoxins implicated in these diseases include Shiga toxin and the closely related Stx. Stx variants are expressed in <italic>Shigella, Enterobacter, Citrobacter, Acinetobacter, Campylobacter</italic>, and <italic>Hamiltonella</italic> bacterial species (<xref ref-type="bibr" rid="B19">Mauro and Koudelka, 2011</xref>). <xref ref-type="bibr" rid="B2">Alperi and Figueras (2010)</xref> described the presence of Stx1 and Stx2 in clinical isolates of <italic>Aeromonas</italic> spp., associated with gastroenteritis, hemorrhagic colitis, and HUS. Genes encoding these toxins are located in different lambdoid bacteriophages that lysogenize this strain. In addition, the genus <italic>Aeromonas</italic> has a zero-secretion system named OMVs. OMVs could be a means by which some proteins, RNA, periplasmic space components and other components associated with virulence, may be transferred horizontally to other genera; therefore, it is believed that OMVs play an important role in pathogenicity (<xref ref-type="bibr" rid="B12">Guerrero-Mandujano et al., 2015a</xref>,<xref ref-type="bibr" rid="B13">b</xref>).</p>
<p>For this reason, the aim of this study was to evaluate the damage caused by the production of Stx by strains isolated from Mexico City children in Vero cell cultures.</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec><title>Strains</title>
<p>This study included 66 clinical isolates from the INP, 54 obtained from intestinal and 12 from extra-intestinal infections. Strains were isolated from specimens obtained for routine testing at the mentioned hospital; therefore, no informed consent was required from parents or legal guardians of children. All strains were genetically identified by 16S rDNA-RFLP (<xref ref-type="bibr" rid="B15">Hern&#x00E1;ndez-Cortez et al., 2011</xref>). The typed strain for <italic>Escherichia coli</italic> O157:H7 CECT 4076 was used as the positive control and <italic>E. coli</italic> K12 strain (5512 ENCB) from the collection of the Medical Bacteriology Laboratory <italic>(Escuela Nacional de Ciencias Biologicas, IPN</italic>) was used as the negative control for toxin production. The strains were maintained for short periods at room temperature on blood agar based slants; for longer storage, they were either frozen at -70&#x00B0;C in 20% (w/v) glycerol-Todd-Hewitt broth (Oxoid, Mexico) or lyophilized in 7.5% horse glucose serum.</p>
</sec>
<sec><title>DNA Extraction</title>
<p>All the cultures were grown on tryptic soy agar at 30&#x00B0;C for 18 h. The genomic DNA of each strain was obtained through InstaGene Matrix (BioRad<sup>&#x00AE;</sup>, Mexico) according to the instructions provided by the manufacturer. DNA purity and quantity were determined by using the Ampli Quant AQ-07 spectrophotometer. DNA was stored at -20&#x00B0;C until use.</p>
</sec>
<sec><title><italic>stx1</italic> and <italic>stx2</italic> PCR Amplifications</title>
<p>The presence of <italic>stx1 and stx2</italic> from DNA of OMVs and genomic DNA was detected by single PCR reactions using primers STX1F/STX1R and STXF/STXR with a 144 and 217 bp product, respectively, these primers were designed based on the sequence of subunit A. The primers, the reaction, and amplification conditions were processed as previously described by <xref ref-type="bibr" rid="B16">Hern&#x00E1;ndez-Cortez et al. (2013)</xref>, with the positive (<italic>E. coli</italic> O157:H7) and negative (<italic>E. coli</italic> K12) controls.</p>
</sec>
<sec><title>DNA Sequencing</title>
<p>Polymerase chain reaction products were purified using a PureLink Quick Gel Extraction Kit (Invitrogen<sup>&#x00AE;</sup>, Mexico) according to manufacturer&#x2019;s instructions. The products were directly sequenced on an ABI-PRISM 310 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) using the forward and reverse primers used for PCR, according to manufacturer&#x2019;s instructions. Sequencing was performed at the <italic>Instituto de Biolog&#x00ED;a, UNAM</italic> (Mexico). Sequence analysis was performed with the Basic Local Alignment Search Tool (BLAST) provided by the National Center for Biotechnology Information (NCBI).</p>
</sec>
<sec><title>Microplate Vero Cells Preparations</title>
<p>This procedure was performed in 96-well microplates with Vero (ATCC CCL81) cell monolayer with 80% confluence, adding minimal essential medium (MEM; Invitro<sup>&#x00AE;</sup>, Mexico) supplemented with 10% v/v fetal bovine serum (FBS; Invitro<sup>&#x00AE;</sup>, Mexico).</p>
<p>The cell suspension was homogenized and adjusted to 10<sup>5</sup>&#x2013;10<sup>6</sup> cells/mL using a Neubauer chamber. After adjusting, the suspension was deposited in 200-&#x03BC;L well. The microplates were incubated at 37&#x00B0;C under 5% CO<sub>2</sub> for 24 h (CO<sub>2</sub> Incubator, VWR Scientific, USA) (<xref ref-type="bibr" rid="B11">Giono-Cerezo et al., 1994</xref>).</p>
</sec>
<sec><title>Cell-Free Bacterial Preparations</title>
<p>Five colonies from each blood agar plate were inoculated into 3 mL of Craig medium (0.4% yeast extract, 3% casamino acids, 0.05% K<sub>2</sub>HPO<sub>4</sub>). These were incubated for 24 h at 37&#x00B0;C and the optical density of the bacterial culture used was 0.25 at 600 nm. Cell-free preparations were made by centrifuging the cultures at 14,000 <italic>g</italic> for 10 min at 4&#x00B0;C, followed by filtration of the supernatant through a membrane filter (pore size 0.45 pm, Sartorius Minisart NML). Cell-free supernatants were stored at -20&#x00B0;C. A total of 66 cell-free bacterial preparations were obtained in this way; the positive control (<italic>E. coli</italic> O157:H7) and the negative control (<italic>E. coli</italic> K12) were obtained also in the same way (<xref ref-type="bibr" rid="B11">Giono-Cerezo et al., 1994</xref>).</p>
</sec>
<sec><title>Cytotoxic Assay and LD<sub>50</sub> Determination</title>
<p>The cell-free filtrate (20 &#x03BC;L) was inoculated into wells containing cells and the respective growth medium without antibiotics. Inoculated cells were incubated for 96 h at 37&#x00B0;C with 5% CO<sub>2</sub> and observed every 24 h on the inverted microscope. The cytotoxic effect was expected to appear as rounding and shrinkage of cells with thick granulation and, finally, progressive and irreversible destruction of the monolayer. All tests were performed in duplicate; viability controls with MEM and Craig medium were performed also (<xref ref-type="bibr" rid="B11">Giono-Cerezo et al., 1994</xref>).</p>
<p>The LD<sub>50</sub> was determined in <italic>Aeromonas</italic> strains detected as positive for causing cytotoxic damage in Vero cells. A standard 96-well microplate with Vero cells was prepared as indicated in 2.6, but the medium was changed to 100 &#x03BC;L of MEM with 1% BFS. This preparation was exposed to 100 &#x03BC;L of cell -free bacterial preparation, and serial dilutions were done on the whole row of plates. After 24 h of incubation at 37&#x00B0;C with 5% CO<sub>2</sub>, the LD<sub>50</sub> was determined, under the inverted microscope. LD<sub>50</sub> was assigned to the well in which 50% of Vero cells were damaged and 50% un-damaged (<xref ref-type="bibr" rid="B18">Marques et al., 1986</xref>).</p>
</sec>
<sec><title>Blockade and Toxin Neutralization Assay</title>
<p>The toxin neutralization assay was performed in the strains that induced cytotoxic damage in Vero cells because this damage is indicative of Stx. For this test, a microplate was prepared with Vero cell grown to a confluence of 90&#x2013;100% with the LD<sub>50</sub> of each cell-free bacterial preparation. To perform the neutralization assay to show cell damage produced as a consequence of Stx action, two monoclonal antibodies (<italic>Universidad Nacional Aut&#x00F3;noma de M&#x00E9;xico</italic>) obtained from <italic>E. coli</italic> O157:H7 were used.</p>
<p>For each Ab a Bradford protein quantitation was done according to manufacturer&#x2019;s instructions (Biorad), with a result of 78.2 and 74.8 &#x03BC;g/&#x03BC;L, respectively, of anti-Stx1 and anti-Stx2 A. The concentrated Ab was worked and a double dilution of the Ab. Then, 10 &#x03BC;L of the Ab (anti-STX1 or anti-STX2) was incubated with 190 &#x03BC;L of the cell-free supernatant at a concentration of LD<sub>50</sub> for 1 h at 37&#x00B0;C. Following this, 200 &#x03BC;L of the latter was inoculated into Vero cells at 90% of confluence and incubated for 24 h at 37&#x00B0;C with 5% CO<sub>2</sub> (<xref ref-type="bibr" rid="B18">Marques et al., 1986</xref>).</p>
</sec>
<sec><title>OMVs Procurement and DNA Extraction from OMVs</title>
<p>Outer membrane vesicles were obtained from <italic>Aeromonas hydrophila</italic> F-0050. The protocol was performed as previously described by <xref ref-type="bibr" rid="B12">Guerrero-Mandujano et al. (2015a)</xref>.</p>
<p>The OMVs&#x2019; DNA was obtained through InstaGene Matrix (BioRad<sup>&#x00AE;</sup>, Mexico) according to the instructions provided by the manufacturer. Then, the OMVs&#x2019; DNA was purified with the DNA extraction phenol-chloroform technique (<xref ref-type="bibr" rid="B13">Guerrero-Mandujano et al., 2015b</xref>).</p>
</sec>
</sec>
<sec><title>Results</title>
<sec><title><italic>stx1</italic> and <italic>stx2</italic> Gene PCR Amplifications</title>
<p>Polymerase chain reaction screening of 66 clinical <italic>Aeromonas</italic> strains showed that 22/66 (33.3%) strains contained the <italic>stx1</italic> gene, 42/66 (63.6%) strains contained both genes, no strains contained only the <italic>stx2</italic> gene, and 2/66 (3%) strains were negative for both genes.</p>
</sec>
<sec><title>DNA Sequencing</title>
<p>BLASTn analysis showed a 79 to 99% similarity and an expected value of 3e-16/2e-97 between the <italic>stx-1/stx-2</italic> genes of <italic>E. coli</italic> O157:H7 and the amplicon from <italic>Aeromonas</italic> spp., strains.</p>
</sec>
<sec><title>Cytotoxic Assay and LD<sub>50</sub> Determination</title>
<p>The cytotoxicity test performed in Vero cell cultures showed that 17/66 (25.7%) cell-free bacterial preparations caused cytotoxic damage, suggesting production of an active Stx (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>), revealed by the characteristic damage caused by Stx.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p><bold>Cytotoxicity assay and LD<sub>50</sub> determination performed in Vero cell cultures. (A)</bold> Vero cell culture with Minimal Essential Medium (Viability test). <bold>(B)</bold> Vero cell culture with Craig Medium (Viability test). <bold>(C)</bold> Negative control with <italic>E. coli</italic> K12. <bold>(D)</bold> Positive control with <italic>E. coli</italic> O157: H7, Cytotoxic damage is shown (arrows) by destruction of the cell monolayer and &#x201C;old lace&#x201D; effect. <bold>(E)</bold> Cytotoxic damage of <italic>A. hydrophila</italic> F-0050 strain. <bold>(F)</bold> Cytotoxic damage of <italic>A. caviae</italic> 421423 strain. <bold>(G)</bold> Graphical representation of the LD<sub>50</sub> titer of all strains.</p></caption>
<graphic xlink:href="fmicb-07-01522-g001.tif"/>
</fig>
<p>The results for determining the LD<sub>50</sub> titer were as follows: 6/17 (35.2%) cell-free bacterial preparations presented a titer of 1:16; 5/17 (29.4%) cell-free bacterial preparations depicted a titer of 1:8; 3/17 (17.6%) cell-free bacterial preparations had a titer of 1:64; 2/17 (11.7%) cell-free bacterial preparations with a titer of 1:32; and 1/17 (5.8%) cell-free bacterial preparations with a titer of 1:256 (<bold>Figure <xref ref-type="fig" rid="F1">1G</xref></bold>).</p>
</sec>
<sec><title>Toxin Neutralization</title>
<p>The application of anti-STX1 Ab in 11/17 (64.7%) strains the damage to cells in the supernatant was completely inhibited at 39.1 &#x03BC;g/&#x03BC;L Ab concentration; in 4/17 (23.5%) cell-free bacterial preparations, reduced cell damage was observed at the same concentration; and in 2/17 (11.7%) cell-free bacterial preparations, cell damage was completely inhibited at a concentration 78.2 &#x03BC;g/&#x03BC;L. Using the Ab anti-STX2 showed that in 9/17 (52.9%) cell-free bacterial preparations, cell damage was totally inhibited at 37.4 &#x03BC;g/&#x03BC;L, and 6/17 (35.2%) cell-free bacterial preparations showed reduced cell damage at the same concentration; and in 2/17 (11.7%) cell-free bacterial preparations, cell damage was completely inhibited with an Ab concentration of 74.8 &#x03BC;g/&#x03BC;L (<bold>Figures <xref ref-type="fig" rid="F2">2</xref></bold> and <bold><xref ref-type="fig" rid="F3">3</xref></bold>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p><bold>Inhibition of cytotoxic effect induced in Vero cells culture by cell-free bacterial preparations of <italic>Aeromonas</italic> spp. strains bearing the <italic>stx1</italic> or <italic>stx2</italic> gene</bold>.</p></caption>
<graphic xlink:href="fmicb-07-01522-g002.tif"/>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p><bold>Percentage of strains that showed inhibition or reduction of cell damage. (A)</bold> Neutralization with the anti-Stx1 Ab. <bold>(B)</bold> Neutralization with the anti-Stx2 Ab.</p></caption>
<graphic xlink:href="fmicb-07-01522-g003.tif"/>
</fig>
</sec>
<sec><title><italic>stx1</italic> Gene PCR Amplifications from OMVs</title>
<p>Polymerase chain reaction of OMVs&#x2019; DNA of <italic>A. hydrophila</italic> F-0050 revealed the OMVs contained the gen <italic>stx1</italic>; hence, OMVs might be a potential vehicle for horizontal virulence genes transfer (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p><bold>Electropherogram of <italic>stx1</italic> gene amplification from OMVs&#x2019; DNA.</bold> (1) Kapa Universal Ladder, (2) Negative control, (3) OMVs of <italic>A. hydrophila</italic> F-0050, (4) <italic>A. hydrophila</italic> F-0050, (5) OMVs of <italic>E. coli</italic> O157:H7, and (6) <italic>E. coli</italic> O157:H7.</p></caption>
<graphic xlink:href="fmicb-07-01522-g004.tif"/>
</fig>
</sec>
</sec>
<sec><title>Discussion</title>
<p>The genus <italic>Aeromonas</italic>, as a producer of Stx, could be an emergent pathogen that causes diarrhea mainly in pediatric patients (<xref ref-type="bibr" rid="B15">Hern&#x00E1;ndez-Cortez et al., 2011</xref>; <xref ref-type="bibr" rid="B7">Figueras and Baez-Hidalgo, 2014</xref>). Nevertheless, this genus has become more relevant in the medical area, as it is a pathogen causing HUS (<xref ref-type="bibr" rid="B22">San Joaqu&#x00ED;n and Pickett, 1988</xref>; <xref ref-type="bibr" rid="B3">Bogdanovi&#x0107; et al., 1991</xref>; <xref ref-type="bibr" rid="B21">Robson et al., 1992</xref>; <xref ref-type="bibr" rid="B6">Fang et al., 1999</xref>; <xref ref-type="bibr" rid="B20">Monforte-Cirac et al., 2010</xref>).</p>
<p>In this study, we found, by PCR amplification of the <italic>stx1</italic> and <italic>stx2</italic> genes, that 22/66 (33.3%) of the aeromonad strains contained the <italic>stx1 gene</italic>, 42/66 (63.6%) strains contained both genes, and there were no strains containing <italic>stx2</italic> alone. This can lead us to suggest that this gene is widely distributed in the <italic>Aeromonas</italic> strains isolated from pediatric patients and that these patients can be at risk for developing HUS.</p>
<p>There is only one previous report in which the <italic>stx</italic> genes were studied in <italic>Aeromonas</italic> strains isolated from different hospitals in Spain; the results obtained were that 19/80 (23.7%) strains had the <italic>stx1</italic> gene and only 1/80 (1.25%) strain was positive for both genes (<xref ref-type="bibr" rid="B2">Alperi and Figueras, 2010</xref>). These results convey that there is a greater distribution of the gene in Mexican strains; however, we should take into account that, in Spain, the <italic>Aeromonas</italic> genus is a known gastrointestinal pathogen isolated routinely in patients with a gastrointestinal profile, therefore, an adequate treatment is given to confront this genus.</p>
<p>In Mexico, this genus is not included in the list of pathogens causing diarrhea and it is not isolated routinely; as a result, it is difficult to give any treatment and good quality of life to patients; moreover, there are no statistics about its prevalence. In addition, the genus becomes more relevant due to the socioeconomic conditions of the Mexican population, which include water shortage; this facilitates its transmission and increases the possibility of HUS becoming a public health problem.</p>
<p>Sequencing of the amplicons was carried out and a Blast search was performed, which showed 79&#x2013;99% similarity and an expectancy value of 3e-16/2e-97 between genes <italic>stx1/stx2</italic> as compared to <italic>E. coli</italic> O157:H7.</p>
<p>The LD<sub>50</sub> was determined to evaluate the cytotoxic damage in Vero cell culture; with this parameter and based on <xref ref-type="bibr" rid="B18">Marques et al. (1986)</xref>, the strains can be grouped in low (2 &#x00D7; 10<sup>1</sup> to 6 &#x00D7; 10<sup>2</sup>), moderate (10<sup>3</sup>&#x2013;10<sup>4</sup>), and high (10<sup>5</sup>&#x2013;10<sup>8</sup>) production (<bold>Figure <xref ref-type="fig" rid="F1">1G</xref></bold>). <xref ref-type="bibr" rid="B18">Marques et al. (1986)</xref> carried out a study in which they made a similar assay to that of the present study, but with different strains of STEC, they obtained that 262/400 (63%) strains were grouped as low Stx producers, and 48% produced cytotoxic damage; nevertheless, in 40% of these strains the cytotoxic damage was inhibited with anti-Stx antibodies.</p>
<p>In the present study, 25.7% of bacteria-free preparations caused cytotoxic damage characteristic of Stx in Vero cells, suggesting production of active Stx, all <italic>Aeromonas</italic> strains were grouped as low producers of Stx; however, in 50&#x2013;70% of the cell-free supernatants, the cellular damage was inhibited, and in 20&#x2013;30% of cell-free supernatants the cellular damage was reduced (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). The cell-free supernatants in which cellular damage was reduced this could have been because of two variants in the toxin present in the supernatant, consequently, as they are different immunologically, the Stx could not be totally inhibited and the cellular damage remained (<xref ref-type="bibr" rid="B18">Marques et al., 1986</xref>).</p>
<p>Two previous studies (<xref ref-type="bibr" rid="B14">Haque et al., 1996</xref>; <xref ref-type="bibr" rid="B2">Alperi and Figueras, 2010</xref>) obtained 10.2% and 10.53% of Stx1-producing <italic>Aeromonas</italic> strains, respectively. The reason for a higher percentage of <italic>Aeromonas</italic> strains producing active Stx could be due to the high availability of the Stx bacteriophage inside the culture as some STEC strains carriers of the Stx bacteriophage have been isolated from urban wastewater from treatment plants, wastewater from slaughterhouses and cattle stools (<xref ref-type="bibr" rid="B9">Garc&#x00ED;a-Aljaro et al., 2004</xref>, <xref ref-type="bibr" rid="B10">2009</xref>). Similarly transduction studies have been carried out <italic>in vivo</italic> with Stx phages from <italic>E. coli</italic>, which can infect intestinal microbiota bacteria, giving the toxigenic characteristic to strains that were not infected before (<xref ref-type="bibr" rid="B1">Acheson et al., 1998</xref>; <xref ref-type="bibr" rid="B23">Schmidt et al., 1999</xref>; <xref ref-type="bibr" rid="B8">Gamage et al., 2003</xref>). The same could happen with the genus <italic>Aeromonas</italic> when inducing a gastrointestinal profile, followed by the fact that the genus <italic>Aeromonas</italic> has the ability to capture and integrate virulence factors in its genome, and one of these is the Stx-encoding gene.</p>
<p>The rest of the strains caused cytotonic damage in the cell, possibly suggesting production of different toxins other than Stx, since <italic>Aeromonas</italic> is a genus capable of producing two cytotonic enterotoxins, thermostable (AST) and thermolabile (ALT) (<xref ref-type="bibr" rid="B7">Figueras and Baez-Hidalgo, 2014</xref>), that can cause cytotonic damage in Vero cells; another possibility is that the <italic>Aeromonas</italic> strains have more than one bacteriophage inserted in their genome, as it has been demonstrated that STEC strains with double lysogeny are able to regulate bacteriophages to inhibit the capacity of lytic cycle induction, which results in a decrease of Stx production but without losing the gene (<xref ref-type="bibr" rid="B9">Garc&#x00ED;a-Aljaro et al., 2004</xref>; <xref ref-type="bibr" rid="B17">Imamovic and Muniesa, 2011</xref>). Therefore, it is necessary to establish how many bacteriophages do <italic>Aeromonas</italic> strains contain, including in the present study, to be able to correlate the presence of Stx bacteriophages and the amount produced of Stx.</p>
<p>On the other hand, the presence of Stx bacteriophages in inducible <italic>Aeromonas</italic> represents a horizontal transfer mechanism of the <italic>stx</italic> gene, but it is not the only one. In more recent studies, it has been determined that <italic>Aeromonas</italic> are capable of producing OMVs (<xref ref-type="bibr" rid="B12">Guerrero-Mandujano et al., 2015a</xref>) and these OMVs are capable of transporting integrated DNA (<xref ref-type="bibr" rid="B13">Guerrero-Mandujano et al., 2015b</xref>). In the present study, we amplified the <italic>stx1</italic> gene from the DNA extracted from the OMVs of one <italic>A. hydrophila</italic> strain of clinical origin, which induced cytotoxic damage in Vero cells, and this damage was inhibited with anti-Stx antibodies. This indicates that the Stx bacteriophage is the transport mechanism of the <italic>stx</italic> gene; furthermore, the OMVs and the recently called Transport System Type 0 are capable of spreading the <italic>stx</italic> gene interspecies or intraspecies. Nevertheless, it is required to confirm if the gene contained in the OMVs is complete. The results obtained in this study support the hypothesis that the <italic>stx</italic> gene is another putative virulence factor of <italic>Aeromonas</italic> that might be transferred through OMVs. It could represent another mechanism for horizontal transport of the <italic>stx</italic> gene to other <italic>Aeromonas</italic> strains and/or other bacterial genera.</p>
<p>For this reason, this genus should be included as possible causative agent of gastroenteritis when trying to identify causal agents and should be reported as part of standard health surveillance procedures.</p>
</sec>
<sec><title>Author Contributions</title>
<p>IP-M and AG-M performed the experiments and MR-R performed the bioinformatics analyses and drafted the manuscript; CH-C designed the primer; VB-G, and JM-L critically commented and revised the manuscript; GC-E conceived the study, participated in its design and coordination, assessed the data and drafted the manuscript. All authors read and approved the final manuscript. We would like to thank Sofia Marteli Mulia for kindly correcting the style of the manuscript.</p>
</sec>
<sec><title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> GC-E and VB-G received support from <italic>Est&#x00ED;mulos al Desempe&#x00F1;o en Investigaci&#x00F3;n and Comisi&#x00F3;n y Fomento de Actividades Acad&#x00E9;micas (Instituto Polit&#x00E9;cnico Nacional)</italic> and <italic>Sistema Nacional de Investigadores (SNI, CONACyT</italic>). This study was funded by the <italic>Secretar&#x00ED;a de Investigaci&#x00F3;n y Posgrado del Instituto Polit&#x00E9;cnico Nacional (SIP 20160609)</italic>. The SIP-IPN was not involved in the development of the study design, the collection, analysis, and interpretation of data, in the writing of the report nor in the decision to submit the paper for publication. IP-M and AG-M held a scholarship from <italic>CONACyT</italic> and <italic>BEIFI</italic>.</p>
</fn>
</fn-group>
<ack>
<p>We thank Dr. Patricia Arzate Barbosa for providing strain isolates and Dr. Armando Navarro for providing the monoclonal antibodies.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Acheson</surname> <given-names>D. W.</given-names></name> <name><surname>Reidl</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Keusch</surname> <given-names>G. T.</given-names></name> <name><surname>Mekalanos</surname> <given-names>J. J.</given-names></name> <name><surname>Waldor</surname> <given-names>M. K.</given-names></name></person-group> (<year>1998</year>). <article-title>In vivo transduction with shiga toxin 1-encoding phage.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>66</volume> <fpage>4496</fpage>&#x2013;<lpage>4498</lpage>.</citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alperi</surname> <given-names>A.</given-names></name> <name><surname>Figueras</surname> <given-names>M. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Human isolates of <italic>Aeromonas</italic> possess shiga toxin genes (stx1 and stx2) highly similar to the most virulent gene variants of <italic>Escherichia coli</italic>.</article-title> <source><italic>Clin. Microbiol. Infect.</italic></source> <volume>16</volume> <fpage>1563</fpage>&#x2013;<lpage>1567</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03203.x</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bogdanovi&#x0107;</surname> <given-names>R.</given-names></name> <name><surname>&#x010C;obelji&#x0107;</surname> <given-names>M.</given-names></name> <name><surname>Markovi&#x0107;</surname> <given-names>M.</given-names></name> <name><surname>Nikoli&#x0107;</surname> <given-names>V.</given-names></name> <name><surname>Ognjanovi&#x0107;</surname> <given-names>M.</given-names></name> <name><surname>Sarjanovi&#x0107;</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>1991</year>). <article-title>Haemolytic-uraemic syndrome associated with <italic>Aeromonas hydrophila</italic> enterocolitis.</article-title> <source><italic>Pediatr. Nephrol.</italic></source> <volume>5</volume> <fpage>293</fpage>&#x2013;<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1007/BF00867480</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castro-Escarpulli</surname> <given-names>G.</given-names></name> <name><surname>Aguilera-Arreola</surname> <given-names>M. G.</given-names></name> <name><surname>Giono-Cerezo</surname> <given-names>S.</given-names></name> <name><surname>Hern&#x00E1;ndez-Rodr&#x00ED;guez</surname> <given-names>C. H.</given-names></name> <name><surname>Rodr&#x00ED;guez-Chac&#x00F3;n</surname> <given-names>M.</given-names></name> <name><surname>Soler</surname> <given-names>F. L.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>El g&#x00E9;nero <italic>Aeromonas</italic>&#x003E; Un pat&#x00F3;geno importante en M&#x00E9;xico?</article-title> <source><italic>Enf. Infec. Micro.</italic></source> <volume>22</volume> <fpage>206</fpage>&#x2013;<lpage>216</lpage>.</citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castro-Escarpulli</surname> <given-names>G.</given-names></name> <name><surname>Figueras</surname> <given-names>M. J.</given-names></name> <name><surname>Aguilera-Arreola</surname> <given-names>M. G.</given-names></name> <name><surname>Soler</surname> <given-names>L.</given-names></name> <name><surname>Fern&#x00E1;ndez-Rend&#x00F3;n</surname> <given-names>E.</given-names></name> <name><surname>Aparicio</surname> <given-names>G. O.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Characterization of <italic>Aeromonas</italic> spp. isolated from frozen fish intended for human consumption in Mexico.</article-title> <source><italic>Int. J. Food Microbiol.</italic></source> <volume>84</volume> <fpage>41</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/S0168-1605(02)00393-8</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname> <given-names>J. S.</given-names></name> <name><surname>Chen</surname> <given-names>J. B.</given-names></name> <name><surname>Chen</surname> <given-names>W. J.</given-names></name> <name><surname>Hsu</surname> <given-names>K. T.</given-names></name></person-group> (<year>1999</year>). <article-title>Haemolytic-ureaemic syndrome in an adult male with <italic>Aeromonas hydrophila</italic> enterocolitis.</article-title> <source><italic>Nephrol. Dial. Transplant.</italic></source> <volume>14</volume> <fpage>439</fpage>&#x2013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1093/ndt/14.2.439</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Figueras</surname> <given-names>M. J.</given-names></name> <name><surname>Baez-Hidalgo</surname> <given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>&#x201C;<italic>Aeromonas</italic>,&#x201D; in</article-title> <source><italic>Encyclopedia of Food Microbiology</italic></source> <role>eds</role> <person-group person-group-type="editor"><name><surname>Batt</surname> <given-names>C. A.</given-names></name> <name><surname>Tortorello</surname> <given-names>M. L.</given-names></name></person-group> (<publisher-loc>Cambridge, MA</publisher-loc>: <publisher-name>Academic Press</publisher-name>) <fpage>24</fpage>&#x2013;<lpage>30</lpage>.</citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gamage</surname> <given-names>S. D.</given-names></name> <name><surname>Strasser</surname> <given-names>J. E.</given-names></name> <name><surname>Chalk</surname> <given-names>C. L.</given-names></name> <name><surname>Weiss</surname> <given-names>A. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Nonpathogenic <italic>Escherichia coli</italic> can contribute to the production of shiga toxin.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>71</volume> <fpage>3107</fpage>&#x2013;<lpage>3115</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.71.6.3107-3115.2003</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x00ED;a-Aljaro</surname> <given-names>C.</given-names></name> <name><surname>Muniesa</surname> <given-names>M.</given-names></name> <name><surname>Jofre</surname> <given-names>J.</given-names></name> <name><surname>Blanch</surname> <given-names>A. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Prevalence of the stx2 gene in coliform populations from aquatic environments.</article-title> <source><italic>Appl. Environ. Microbiol.</italic></source> <volume>70</volume> <fpage>3535</fpage>&#x2013;<lpage>3540</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.70.6.3535-3540.2004</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x00ED;a-Aljaro</surname> <given-names>C.</given-names></name> <name><surname>Muniesa</surname> <given-names>M.</given-names></name> <name><surname>Jofre</surname> <given-names>J.</given-names></name> <name><surname>Blanch</surname> <given-names>A. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Genotypic and phenotypic diversity among induced, stx2-carrying bacteriophages from environmental <italic>Escherichia coli</italic> strains.</article-title> <source><italic>Appl. Environ. Microbiol.</italic></source> <volume>75</volume> <fpage>329</fpage>&#x2013;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01367-08</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giono-Cerezo</surname> <given-names>S.</given-names></name> <name><surname>Rodr&#x00ED;guez-&#x00C1;ngeles</surname> <given-names>M. G.</given-names></name> <name><surname>Rodr&#x00ED;guez-Cadena</surname> <given-names>M. J.</given-names></name> <name><surname>Valdespino-G&#x00F3;mez</surname> <given-names>J. L.</given-names></name></person-group> (<year>1994</year>). <article-title>Identification of enterotoxins and cytotoxins of <italic>Escherichia coli</italic> by vero cell culture and solid-phase hybridization (colony blot).</article-title> <source><italic>Rev. Latinoam. Microbiol.</italic></source> <volume>36</volume> <fpage>231</fpage>&#x2013;<lpage>241</lpage>.</citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guerrero-Mandujano</surname> <given-names>A.</given-names></name> <name><surname>L&#x00F3;pez-Villegas</surname> <given-names>E. O.</given-names></name> <name><surname>Longa-Brise&#x00F1;o</surname> <given-names>A.</given-names></name> <name><surname>Castro-Escarpulli</surname> <given-names>G.</given-names></name></person-group> (<year>2015a</year>). <article-title>Production of outer membrane vesicles in a clinical strain of <italic>Aeromonas hydrophila</italic>.</article-title> <source><italic>EC Microbiol.</italic></source> <volume>1</volume> <fpage>113</fpage>&#x2013;<lpage>117</lpage>.</citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guerrero-Mandujano</surname> <given-names>A.</given-names></name> <name><surname>Palma-Mart&#x00ED;nez</surname> <given-names>I.</given-names></name> <name><surname>Castro-Escarpulli</surname> <given-names>G.</given-names></name></person-group> (<year>2015b</year>). <article-title>Transport DNA by outer membrane vesicles of <italic>Aeromonas hydrophila</italic>.</article-title> <source><italic>EC Microbiol.</italic></source> <volume>2</volume> <fpage>354</fpage>&#x2013;<lpage>357</lpage>.</citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haque</surname> <given-names>Q. M.</given-names></name> <name><surname>Sugiyama</surname> <given-names>A.</given-names></name> <name><surname>Iwade</surname> <given-names>Y.</given-names></name> <name><surname>Midorikawa</surname> <given-names>Y.</given-names></name> <name><surname>Yamauchi</surname> <given-names>T.</given-names></name></person-group> (<year>1996</year>). <article-title>Diarrheal and environmental isolates of <italic>Aeromonas</italic> spp. produce a toxin similar to shiga-like toxin 1.</article-title> <source><italic>Curr. Microbiol.</italic></source> <volume>32</volume> <fpage>239</fpage>&#x2013;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1007/s002849900043</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x00E1;ndez-Cortez</surname> <given-names>C.</given-names></name> <name><surname>Aguilera-Arreola</surname> <given-names>M. G.</given-names></name> <name><surname>Ch&#x00E1;vez-M&#x00E9;ndez</surname> <given-names>Y.</given-names></name> <name><surname>Arzate-Barbosa</surname> <given-names>P.</given-names></name> <name><surname>Lara-Hern&#x00E1;ndez</surname> <given-names>A.</given-names></name> <name><surname>Castro-Escarpulli</surname> <given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Identificaci&#x00F3;n gen&#x00E9;tica de cepas de <italic>Aeromonas</italic> spp. aisladas en el instituto nacional de pediatr&#x00ED;a.</article-title> <source><italic>Rev. Enfer. Infecc. Pediatr.</italic></source> <volume>24</volume> <fpage>157</fpage>&#x2013;<lpage>165</lpage>.</citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x00E1;ndez-Cortez</surname> <given-names>C.</given-names></name> <name><surname>M&#x00E9;ndez-Tenorio</surname> <given-names>A.</given-names></name> <name><surname>Aguilera-Arreola</surname> <given-names>M. G.</given-names></name> <name><surname>Castro-Escarpulli</surname> <given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Design and standardization of four multiplex polymerase chain reactions to detect bacteria that cause gastrointestinal diseases.</article-title> <source><italic>Afr. J. Microbiol. Res.</italic></source> <volume>7</volume> <fpage>2673</fpage>&#x2013;<lpage>2681</lpage>. <pub-id pub-id-type="doi">10.5897/AJMR2013.5452</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imamovic</surname> <given-names>L.</given-names></name> <name><surname>Muniesa</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Quantification and evaluation of infectivity of shiga toxin-encoding bacteriophages in beef and salad.</article-title> <source><italic>Appl. Environ. Microbiol.</italic></source> <volume>77</volume> <fpage>3536</fpage>&#x2013;<lpage>3540</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.02703-10</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname> <given-names>L. R. M.</given-names></name> <name><surname>Moore</surname> <given-names>M. A.</given-names></name> <name><surname>Wells</surname> <given-names>J. G.</given-names></name> <name><surname>Wachsmuth</surname> <given-names>I. K.</given-names></name> <name><surname>O&#x2019;Brien</surname> <given-names>A. D.</given-names></name></person-group> (<year>1986</year>). <article-title>Production of shiga-like toxin by <italic>Escherichia coli</italic>.</article-title> <source><italic>J. Infect. Dis.</italic></source> <volume>154</volume> <fpage>338</fpage>&#x2013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/154.2.338</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mauro</surname> <given-names>S. A.</given-names></name> <name><surname>Koudelka</surname> <given-names>G. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Shiga toxin: expression, distribution, and its role in the environment.</article-title> <source><italic>Toxins</italic></source> <volume>3</volume> <fpage>608</fpage>&#x2013;<lpage>625</lpage>. <pub-id pub-id-type="doi">10.3390/toxins3060608</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monforte-Cirac</surname> <given-names>M. L.</given-names></name> <name><surname>Palacian-Ruiz</surname> <given-names>M. P.</given-names></name> <name><surname>Aisa-Iriarte</surname> <given-names>M. L.</given-names></name> <name><surname>Espuelas-Monge</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>S&#x00ED;ndrome hemol&#x00ED;tico ur&#x00E9;mico por <italic>Aeromonas</italic>: a prop&#x00F3;sito de un caso cl&#x00ED;nico.</article-title> <source><italic>Rev. Clin. Esp.</italic></source> <volume>210</volume> <fpage>206</fpage>&#x2013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1016/j.rce.2009.08.002</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robson</surname> <given-names>W. L. M.</given-names></name> <name><surname>Leung</surname> <given-names>A. K. C.</given-names></name> <name><surname>Trevenen</surname> <given-names>C. L.</given-names></name></person-group> (<year>1992</year>). <article-title>Haemolytic-uraemic syndrome associated with <italic>Aeromonas</italic> hydrophila enterocolitis.</article-title> <source><italic>Pediatr. Nephrol.</italic></source> <volume>6</volume> <fpage>221</fpage>&#x2013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1007/BF00866324</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>San Joaqu&#x00ED;n</surname> <given-names>V. H.</given-names></name> <name><surname>Pickett</surname> <given-names>D. A.</given-names></name></person-group> (<year>1988</year>). <article-title><italic>Aeromonas</italic>-associated gastroenteritis in children.</article-title> <source><italic>Pediatr. Infect. Dis. J.</italic></source> <volume>7</volume> <fpage>53</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1097/00006454-198801000-00013</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname> <given-names>H.</given-names></name> <name><surname>Bielaszewska</surname> <given-names>M.</given-names></name> <name><surname>Karch</surname> <given-names>H.</given-names></name></person-group> (<year>1999</year>). <article-title>Transduction of enteric <italic>Escherichia coli</italic> isolates with a derivative of shiga toxin 2-encoding bacteriophage f3538 isolated from <italic>Escherichia coli</italic> O157:H7.</article-title> <source><italic>Appl. Environ. Microbiol.</italic></source> <volume>65</volume> <fpage>3855</fpage>&#x2013;<lpage>3861</lpage>.</citation></ref>
</ref-list>
<glossary>
<title>Abbreviations</title>
<def-list id="DL1">
<def-item>
<term>Ab</term>
<def>
<p>Antibody</p>
</def>
</def-item>
<def-item>
<term>HUS</term>
<def>
<p>Hemolytic uremic syndrome</p>
</def>
</def-item>
<def-item>
<term>INP</term>
<def>
<p>Instituto Nacional de Pediatria Mexico</p>
</def>
</def-item>
<def-item>
<term>LD<sub>50</sub></term>
<def>
<p>Median lethal dose</p>
</def>
</def-item>
<def-item>
<term>OMVs</term>
<def>
<p>Outer membrane vesicles</p>
</def>
</def-item>
<def-item>
<term>PCR</term>
<def>
<p>Polymerase chain reaction</p>
</def>
</def-item>
<def-item>
<term>STEC</term>
<def>
<p>Shiga toxin-producing <italic>E. coli</italic></p>
</def>
</def-item>
<def-item>
<term>Stx</term>
<def>
<p>Shiga-like toxin</p>
</def>
</def-item>
<def-item>
<term>TTP</term>
<def>
<p>Thrombotic thrombocytopenic purpura</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>